Robert I Haddad, Lindsay Bischoff, Douglas Ball, Victor Bernet, Erik Blomain, Naifa Lamki Busaidy, Michael Campbell, Paxton Dickson, Quan-Yang Duh, Hormoz Ehya, Whitney S Goldner, Theresa Guo, Megan Haymart, Shelby Holt, Jason P Hunt, Andrei Iagaru, Fouad Kandeel, Dominick M Lamonica, Susan Mandel, Stephanie Markovina, Bryan McIver, Christopher D Raeburn, Rod Rezaee, John A Ridge, Mara Y Roth, Randall P Scheri, Jatin P Shah, Jennifer A Sipos, Rebecca Sippel, Cord Sturgeon, Thomas N Wang, Lori J Wirth, Richard J Wong, Michael Yeh, Carly J Cassara, Susan Darlow
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine therapy in most patients. Surgery is also the main treatment for medullary thyroid carcinoma, and kinase inhibitors may be appropriate for select patients with recurrent or persistent disease that is not resectable. Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used...
August 2022: Journal of the National Comprehensive Cancer Network: JNCCN